Munayer CJ, Maza JG, Aldana PT, San LMR, Ramírez RH, Lázaro CJL, Arias ML

Language: Spanish
References: 14
Page: 468-471
PDF size: 207.76 Kb.

ABSTRACT

We present the results and follow up of ductus arteriosus closure with the Rashkind device. Sixty six devices were implanted in 63 patients, 41 women and 22 men, with a mean age of 8.2 years. We determined the diameter of the duct, the presence or absence of immediate residual leak at 3 months, 6 months, 1 year, and every year of follow-up by ecocardiography. The hemodynamic determinations showed: type A morphology in 49, type C in 7 and type E in 7; with a mean diameter of 4.2 ± 1.4 mm (range of 2.3 to 8.7mm) and a Qp/Qs 2.2 ± 1.5 (range 0.7 to 8.6). Fourty five 17 mm devices and 18 of 12 mm were used. The incidence of immediate residual leak was 65% (n-41); at 24 hrs. Post-procedure was 31.7% (n-20) and at one year 7.9% (n-5). Three patients with persistent leak had implantation of a second Rashkind device and one more patient an endovascular coil, the other patient is waiting for a second oclusor. Minor complications occurred in 15.8% (n-10). Results show an occlusion rate at 24 hrs of 68% and at one year of 92%; no patient presented migration of the device, hemolysis or obstruction of the pulmonary artery branches. We consider that occlusion of the ductus arteriosus with the Rashkind device is a safe and effective option for the treatment of this pathology.

REFERENCES

1. Gross RE, Hubbard JP: Surgical ligation of a patent ductus arteriosus; a report of first successful case. JAMA 1989; 112: 729-731.

2. Rashkind WJ, Cuasso CC: Transcatheter closure of a patent ductus arteriosus: Successful use in a 3.5 kg infant. Pediatr Cardiol 1979; 1: 3-7.

3. Rashkind WJ: Transcatheter treatment of congenital heart disease. Circulation 1983; 67: 711-716.

4. Rashkind WJ, Mullins CE, Hellenbrand WE, Tait MA: Nonsurgical closure of patent ductus arteriosus. Clinical applications of the Rashkind PDA occluser system. Circulation 1987; 75: 583-592.

5. Krickenko A, Benson L, Burrows P, Moes C, McLaughlin P, Freedom R: Angiographic classification of the isolated persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989; 63 (1): 877-880.

6. Gray DT, Fyler DC, Walker AM, Weinstein MC: Clinical autcome and cost of transcatheter as compared with surgical closure of patent ductus arteriosus. N Engl J Med 1993; 329(21): 1517-23.

7. Vázquez Antona CA, Rijlaarsdam M, Gaspar J, Gil Moreno M, Buendía Hernández A, Martínez Ríos MA, et al: Cierre de conducto arterioso persistente transcateterismo. Experiencia inicial. Arch Inst Cardiol Mex 1993; 63(6): 493-9.

8. Galal O, Schmalt AA, Fadely F, Fawzy ME, Wilson N, Mimish L: Transcatheter obliteration of patent ductus arteriosus in a young adult with the Rashkind occluder. Z Kardiol 1993; 82(7): 432-5.

9. Verin V, Fredli B, Oberhansli I, Urban P, Meier B: Closure of patent ductus arteriosus using interventional catheterization. Schweiz Med Wochenschr 1993; 123(12): 530-2.

10. SC Jr. Sousa JE: Cierre percutáneo del conducto arterioso con la técnica de Rashkind. Experiencia inicial del Instituto Dante Pazzanese de Cardiología, Sao Paulo, Brasil. Arch Inst Cardiol Mex 1996; 66(2): 129-37.

11. Zabala-Arguelles JL; García Fernández J, Zunzunnegui-Martínez JL, Camino-López M, Maroto Álvaro E, Maroto-Monadero C: Evolución a mediano plazo en el cierre percutáneo del conducto arterioso con prótesis de Rashkind. An Esp Pediatr 1996; 44(4): 332-6.

12. Sievert H, Ennsien R, Fach A, Merie H, Scherer D, Schrander R, et al: Transcatheter closure of patent ductus arteriosus with the Rashkind occluder. Acute results and angiographic follow-up in adults. Eur Heart J 1996; 18(6): 1014-8.

13. De Moor M, Abbag F, al Fradly F, Galal O: Thrombosis on the Rashkind double umbrella device: a complication of PDA occlusion. Cathet Cardiovasc Diagn 1996; 38(2): 182-8.

14. Huggon IC, Tabatabaei AH, Qureshi SA, Baker EJ, Tynan M: Use of a second transcatheter Rashkind arterial duct occluder for persistent flow after implantation of the first device: Indications and results. Br Heart J 1993; 69(6): 544-50.